RCUS vs. STNE

Last updated Apr 1, 2026

Compare and contrast key facts about Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE).

Performance

RCUS vs. STNE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE). The values are adjusted to include any dividend payments, if applicable.

RCUS vs. STNE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
RCUS Arcus Biosciences, Inc.	-9.36%	60.04%	-22.04%	-7.64%	-48.90%	55.89%	157.03%	-6.22%	7.38%
STNE StoneCo Ltd.	-4.53%	85.57%	-55.80%	91.00%	-44.01%	-79.91%	110.38%	116.32%	-41.18%

Fundamentals

EPS RCUS : -$3.28 STNE : $8.50
PS Ratio RCUS : 9.59 STNE : 0.35
Total Revenue (TTM) RCUS : $240.00M STNE : $10.82B
Gross Profit (TTM) RCUS : $238.00M STNE : $7.41B
EBITDA (TTM) RCUS : -$323.00M STNE : $5.09B

Returns By Period

In the year-to-date period, RCUS achieves a -9.36% return, which is significantly lower than STNE's -4.53% return.

RCUS

• 1D: 4.60%
• 1M: 6.04%
• YTD: -9.36%
• 6M: 58.82%
• 1Y: 175.16%
• 3Y*: 5.80%
• 5Y*: -5.61%
• 10Y*: —

STNE

• 1D: 3.90%
• 1M: -15.95%
• YTD: -4.53%
• 6M: -25.33%
• 1Y: 34.73%
• 3Y*: 13.96%
• 5Y*: -26.14%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RCUS vs. STNE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCUS

RCUS Risk / Return Rank: 93
RCUS Sharpe Ratio Rank: 95
RCUS Sortino Ratio Rank: 91
RCUS Omega Ratio Rank: 89
RCUS Calmar Ratio Rank: 95
RCUS Martin Ratio Rank: 94

STNE

STNE Risk / Return Rank: 63
STNE Sharpe Ratio Rank: 66
STNE Sortino Ratio Rank: 61
STNE Omega Ratio Rank: 61
STNE Calmar Ratio Rank: 63
STNE Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCUS vs. STNE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RCUS	STNE	Difference
Sharpe ratio Return per unit of total volatility	2.69	0.68	+2.02
Sortino ratio Return per unit of downside risk	3.00	1.18	+1.82
Omega ratio Gain probability vs. loss probability	1.38	1.16	+0.22
Calmar ratio Return relative to maximum drawdown	5.92	0.91	+5.01
Martin ratio Return relative to average drawdown	15.25	1.91	+13.34
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RCUS vs. STNE - Sharpe Ratio Comparison

The current RCUS Sharpe Ratio is 2.69, which is higher than the STNE Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of RCUS and STNE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RCUS	STNE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.69	0.68	+2.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.08	-0.41	+0.32
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	-0.15	+0.19

Correlation

The correlation between RCUS and STNE is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RCUS vs. STNE - Dividend Comparison

Neither RCUS nor STNE has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

RCUS vs. STNE - Drawdown Comparison

The maximum RCUS drawdown since its inception was -85.83%, smaller than the maximum STNE drawdown of -92.31%. Use the drawdown chart below to compare losses from any high point for RCUS and STNE.

Drawdown Indicators

	RCUS	STNE	Difference
Max Drawdown Largest peak-to-trough decline	-85.83%	-92.31%	+6.48%
Max Drawdown (1Y) Largest decline over 1 year	-27.78%	-31.40%	+3.62%
Max Drawdown (5Y) Largest decline over 5 years	-85.83%	-89.72%	+3.89%
Current Drawdown Current decline from peak	-55.44%	-84.99%	+29.55%
Average Drawdown Average peak-to-trough decline	-46.46%	-60.53%	+14.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.78%	14.92%	-4.14%

Volatility

RCUS vs. STNE - Volatility Comparison

The current volatility for Arcus Biosciences, Inc. (RCUS) is 17.63%, while StoneCo Ltd. (STNE) has a volatility of 25.16%. This indicates that RCUS experiences smaller price fluctuations and is considered to be less risky than STNE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RCUS	STNE	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.63%	25.16%	-7.53%
Volatility (6M) Calculated over the trailing 6-month period	49.29%	40.93%	+8.36%
Volatility (1Y) Calculated over the trailing 1-year period	65.57%	51.64%	+13.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.24%	64.72%	+2.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.77%	67.88%	+8.89%

Financials